Ranipharma Ltd - Limited company - abbreviated - 11.6

Ranipharma Ltd - Limited company - abbreviated - 11.6


03165707 1.1.14 31.12.14 31.12.14 Company accounts Private Limited Company FY true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure031657072013-12-31031657072014-12-31031657072014-01-012014-12-31031657072012-12-31031657072013-01-012013-12-31031657072013-12-3103165707ns12:England2014-01-012014-12-3103165707ns14:USDollar2014-01-012014-12-3103165707ns7:Director12014-01-012014-12-3103165707ns7:OrdinaryShareClass12014-01-012014-12-3103165707ns7:CompanySecretary2014-01-012014-12-3103165707ns7:RegisteredOffice2014-01-012014-12-3103165707ns7:EntityAccountantsOrAuditors2014-01-012014-12-3103165707ns7:OrdinaryShareClass12014-12-3103165707ns7:OrdinaryShareClass12013-12-31
REGISTERED NUMBER: 03165707 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 31 December 2014

for

Ranipharma Ltd

Ranipharma Ltd (Registered number: 03165707)






Contents of the Abbreviated Accounts
for the Year Ended 31 December 2014




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

Report of the Accountants 4

Ranipharma Ltd

Company Information
for the Year Ended 31 December 2014







DIRECTOR: Mrs M A Seville





SECRETARY: Inter.Gala Corporate Secretaries Ltd





REGISTERED OFFICE: 1st Floor Victory House
99-101 Regent Street
London
W1B 4EZ





REGISTERED NUMBER: 03165707 (England and Wales)





ACCOUNTANTS: Lextray UK Limited
1ST FLOOR VICTORY HOUSE
99-101 REGENT STREET
London
W1B 4EZ

Ranipharma Ltd (Registered number: 03165707)

Abbreviated Balance Sheet
31 December 2014

31.12.14 31.12.13
Notes $    $   
CURRENT ASSETS
Debtors 235 235
Cash at bank 7,073 5,860
7,308 6,095
CREDITORS
Amounts falling due within one year 236,926 180,431
NET CURRENT LIABILITIES (229,618 ) (174,336 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(229,618
)
(174,336
)

PROVISIONS FOR LIABILITIES 1,200 1,213
NET LIABILITIES (230,818 ) (175,549 )

CAPITAL AND RESERVES
Called up share capital 2 1,640 1,640
Profit and loss account (232,458 ) (177,189 )
SHAREHOLDERS' FUNDS (230,818 ) (175,549 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2014 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the director on 12 May 2015 and were signed by:





Mrs M A Seville - Director


Ranipharma Ltd (Registered number: 03165707)

Notes to the Abbreviated Accounts
for the Year Ended 31 December 2014

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
Partner's profit share

Under a partnership agreement dated 12 March 1996, GLP Generic Licencing Programme Limited in entitled to
receive a profit share amounting to 95% of all transactions administered on their behalf by Ranipharma Ltd. This
is included in the cost of sales.

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at
the date of transaction. Exchange differences are taken into account in arriving at the operating result.

2. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.14 31.12.13
value: $    $   
1,000 Ordinary £1 1,640 1,640

3. ULTIMATE PARENT COMPANY

The company's parent companies are Lloyd Andrews (Nominees) Ltd, a company incorporated in the British
Virgin Islands and Offshore Capital Management Corp.,a company incorporated in the Republic of Panama.

Ranipharma Ltd

Report of the Accountants to the Director of
Ranipharma Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual
unaudited financial statements, from which the unaudited abbreviated accounts (set out on pages two to three)
have been prepared.

As described on the balance sheet you are responsible for the preparation of the financial statements for the year ended 31 December 2014 set out on pages nil to nil and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Lextray UK Limited
1ST FLOOR VICTORY HOUSE
99-101 REGENT STREET
London
W1B 4EZ


12 May 2015